CJC-1295 (no DAC)

CJC-1295 (no DAC) is a research peptide studied for its interaction with GHRH (growth hormone-releasing hormone) receptor pathways involved in GH and IGF-1 release. These pathways play a role in cellular signaling, receptor modulation, and downstream biological responses. In research models, CJC-1295 (no DAC) has been associated with changes in GH/IGF-1 release markers and GHRH receptor activity, making it a compound of interest in endocrine and pituitary studies. For research purposes only. Not intended for human or veterinary use.